Announcements

MDPI will be attending the 11th Congress of the European Academy of Neurology, which will be held in Helsinki, Finland, from 21 to 24 June 2025. The EAN Congress 2025 is organized by the European Academy of Neurology. Its exciting overarching theme of neurology within society sets the scene for an unforgettable congress and is highly relevant to our practice as neurologists, given our crucial role as clinicians—and in many cases neuroscientists—in addressing the huge burden of neurological disorders. To have an impact, we must work with many other stakeholders and specialties, and we look forward to welcoming many of them to the home of neurology in 2025. As usual, the overarching theme will serve as a common thread throughout all the invited content of our congress, from workshops to plenary sessions.

The following MDPI journals will be represented:

• Brain Sciences;
• JCM;
• CTN;
• Neurology International;
• Neuroglia;
• Cells;
• Diagnostics;
• Neurosci;
• Psychiatry International;
• Antioxidants;
• Biomolecules;
• Genes;
• IJTM;
• Vaccines.

If you plan to attend the conference, please visit our booth #E48. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.ean.org/congress2025.

Tuberculosis is a disease that is both preventable and treatable, significantly affecting people’s health and quality of life worldwide. Every year, we commemorate World Tuberculosis Day to raise public awareness of the devastating health, social, and economic consequences of tuberculosis (TB) and to intensify efforts to end the global TB epidemic. The date signifies the day in 1882 when Dr. Robert Koch announced his discovery of the bacterium responsible for TB, which paved the way for diagnosing and curing this disease. We hope that established journals in the fields of Biology Life Sciences and Medicine & Pharmacology at MDPI, including Pathogens, Microorganisms, Reports, Medical Sciences, Healthcare and Diagnostics will continue to serve as a communication platform for innovative ideas regarding prevention and treatment.

“Impact of Severity of COVID-19 in TB Disease Patients: Experience from an Italian Infectious Disease Referral Hospital”
by Virginia Di Bari, Carlotta Cerva, Raffaella Libertone, Serena Maria Carli, Maria Musso, Delia Goletti, Alessandra Aiello, Antonio Mazzarelli, Angela Cannas, Giulia Matusali, Fabrizio Palmieri, Gina Gualano and on behalf of the TB-INMI Working Group
Infect. Dis. Rep. 2025, 17(1), 11; https://doi.org/10.3390/idr17010011 

“Cigarette Smoking as a Risk Factor for Tuberculosis in Adults: Epidemiology and Aspects of Disease Pathogenesis”
by Charles Feldman, Annette J. Theron, Moloko C. Cholo and Ronald Anderson
Pathogens 2024, 13(2), 151; https://doi.org/10.3390/pathogens13020151 

“Situation Analysis of Early Implementation of Programmatic Management of Tuberculosis Preventive Treatment among Household Contacts of Pulmonary TB Patients in Delhi, India”
by Yasir Alvi, Sairu Philip, Tanu Anand, Palanivel Chinnakali, Farzana Islam, Neeta Singla, Pruthu Thekkur, Ashwani Khanna and BK Vashishat
Trop. Med. Infect. Dis. 2024, 9(1), 24; https://doi.org/10.3390/tropicalmed9010024 

“HLA-DPB1*05:01 and HLA-A*11:01 Is Associated with Adverse Drug Reactions to Isoniazid and Rifampin for Treatment of Latent Tuberculosis Infection in South Korea”
by Bomi Kim, Jungok Kim, Sun-Young Yoon, Hae Suk Cheong, Min-Jung Kwon, Joon-Sup Yeom, Han-Na Kim and Eun-Jeong Joo
Clin. Med. 2024, 13(12), 3563; https://doi.org/10.3390/jcm13123563 

“Pharmacists’ Role in Global TB Elimination: Practices, Pitfalls, and Potential”
by Alina Cernasev, Jonathan Stillo, Jolie Black, Mythili Batchu, Elaina Bell and Cynthia A. Tschampl
Healthcare 2024, 12(11), 1137; https://doi.org/10.3390/healthcare12111137 

“Metabolic Rewiring of Mycobacterium tuberculosis upon Drug Treatment and Antibiotics Resistance”
by Biplab Singha, Sumit Murmu, Tripti Nair, Rahul Singh Rawat, Aditya Kumar Sharma and Vijay Soni
Metabolites 2024, 14(1), 63; https://doi.org/10.3390/metabo14010063 

“Exploring the Impact of Silicosis Incidence on Tuberculosis Mortality and Morbidity: A Multi-Country Study”
by Muayad Albadrani
Med. Sci. 2023, 11(4), 63; https://doi.org/10.3390/medsci11040063

This year, World Down Syndrome Day will be celebrated on 21 March 2025. Each year, approximately 3,000 to 5,000 children are born with this chromosome disorder. In 2025, we call for people around the world to “end the stereotypes”.

Aiming at improving the quality of life of people with Down syndrome and propelling the scientific development in this field, we would like to recommend some related articles, Special Issues, and journals in MDPI as suitable communication platforms for you. We believe that sharing research like this can help raise awareness of Down syndrome.

“When Language Is Not Enough: How to Explain ToM Abilities of Individuals with Williams Syndrome and Down Syndrome”
by Claire Touchet, Régis Pochon and Laure Ibernon
Disabilities 2025, 5(1), 4; https://doi.org/10.3390/disabilities5010004

“Assessing Uveitis Risk following Pediatric Down Syndrome Diagnosis: A TriNetX Database Study”
by Alan Y. Hsu, Yu-Hsun Wang, Chun-Ju Lin, You-Ling Li, Ning-Yi Hsia, Chun-Ting Lai, Hou-Ting Kuo, Huan-Sheng Chen, Yi-Yu Tsai and James Cheng-Chung Wei
Medicina 2024, 60(5), 710; https://doi.org/10.3390/medicina60050710

“Impact of Resistance Training on Body Composition and Physical Function in Individuals with Down Syndrome: A Meta-Analysis”
by Hou-Ting Kuo, Ting-Hsu Lee, Li-An Su, Li-Yun Wu, Ping-Yan Mao and Ciao-Ci Yang
Diagnostics 2024, 14(23), 2620; https://doi.org/10.3390/diagnostics14232620

“The Role of Tau Pathology in Alzheimer’s Disease and Down Syndrome”
by Ann-Charlotte Granholm and Eric D. Hamlett
J. Clin. Med. 2024, 13(5), 1338; https://doi.org/10.3390/jcm13051338

“Astrocytic Alterations and Dysfunction in Down Syndrome: Focus on Neurogenesis, Synaptogenesis, and Neural Circuits Formation”
by Beatrice Uguagliati and Mariagrazia Grilli
Cells 2024, 13(24), 2037; https://doi.org/10.3390/cells13242037

“Lipid Profile, Eating Habit, and Physical Activity in Children with Down Syndrome: A Prospective Study”
by Luca Pecoraro, Melissa Zadra, Francesco Cavallin, Silvana Lauriola, Giorgio Piacentini and Angelo Pietrobelli
Diseases 2024, 12(4), 68; https://doi.org/10.3390/diseases12040068

“Impact of Physical Activity on Autonomy and Quality of Life in Individuals with Down Syndrome: A Systematic Review”
by Antonio Muñoz-Llerena, Laura Ladrón-de-Guevara, Daniel Medina-Rebollo and Virginia Alcaraz-Rodríguez
Healthcare 2024, 12(2), 181; https://doi.org/10.3390/healthcare12020181

“Health Checks for People with Down Syndrome: A Pooled Analysis of Three Randomized Controlled Trials”
by Robert S. Ware, Catherine Franklin, Lyn McPherson and Nicholas G. Lennox
Disabilities 2024, 4(1), 101-110; https://doi.org/10.3390/disabilities4010007

“DNMT3B rs2424913 as a Risk Factor for Congenital Heart Defects in Down Syndrome”
by Dijana Majstorović, Anita Barišić, Ivana Babić Božović, Iva Bilić Čače, Neven Čače, Mauro Štifanić and Jadranka Vraneković
Genes 2023, 14(3), 576; https://doi.org/10.3390/genes14030576

“Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules”
by Lanzillotta, Chiara, and Fabio Di Domenico
Biomolecules 2021, 11(2), 266; https://doi.org/10.3390/biom11020266

“Role of 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation and Cellular Bioenergetics in Human Down Syndrome Fibroblasts”
by Panagaki, Theodora, Elisa B. Randi, and Csaba Szabo
Biomolecules 2020, 10(4), 653; https://doi.org/10.3390/biom10040653

“The Care Economy and Disability Inclusion”	“Fragile X Syndrome and Fragile X Premutation Associated Conditions”
“Physical Activity, Exercise, and Sport in People with Disabilities: Strategies for Health Promotion”	“Cellular and Molecular Alterations in the Down Syndrome Brain: A Starting Point for the Design of Therapeutic Approaches”

MDPI will attend the 9th European Congress of Virology 2025 (ECV2025) as an exhibitor. This meeting will be held in Cavtat, Croatia, from 27 to 30 April 2025.

ECV provides a unique opportunity for European virologists from all fields of virus research to present their work, exchange ideas, and plan new exciting projects. ECV organizing and scientific committees are busy preparing a high-quality and diverse program for attendees.

The following MDPI journals will be represented at the conference:

• Viruses;
• Pathogens;
• Diagnostics;
• COVID;
• Microbiology Research.

If you are planning to attend the above conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference and our booth, please visit the following website: https://eusv-congress.eu/.

MDPI is pleased to share a significant milestone in its mission to advance scholarly research and promote the dissemination of knowledge—300+ MDPI journals are now indexed in Web of Science (WoS). This milestone highlights the global recognition, interdisciplinary impact and enhanced visibility of our journals. It also reflects our adherence to rigorous editorial standards, scientific integrity, and our mission to foster open scientific exchange in all forms, across all disciplines. 

To explore the full list of our journals indexed in WoS, please visit https://www.mdpi.com/about/journals/wos. Beyond expanding the coverage of our publications in the leading academic databases, we are dedicated to ensuring that our journals are included in as many scope-specific databases as possible. This increases the visibility of our authors’ work and extends the reach of their significant data. 

This milestone would not have been possible without the efforts and expertise of our academic editors, reviewers and authors. Their commitment and collaboration have been instrumental in creating an inclusive, accessible, and impactful publishing platform. We also extend our gratitude to the global research community for their trust as we continue to break new ground in academic publishing. This milestone is not just a celebration of MDPI’s progress but also recognition of the collective strides made by researchers worldwide. 

As we celebrate this remarkable accomplishment, MDPI remains steadfast in its commitment to open access publishing and ensuring that high-quality research reaches and inspires a global audience.

We are pleased to announce that the 2nd International Conference on AI Sensors and Transducers (AIS 2025) will be held in Kuala Lumpur, Malaysia, from 29 July to 3 August 2025. This conference is organized by MDPI’s journals Sensors, AI Sensor, Micromachines, Chemosensors, and Robotics. Building on the success of our previous conference in Singapore, this event promises to be an exciting platform for exploring cutting-edge advances and fostering collaboration in the rapidly evolving field of AI, sensors, and transducers. We expect that the AIS 2025 will host over 600 participants from around the world.

Conference Chairs:

• Prof. Dr. Toshihiro Itoh, Department of Precision Engineering, University of Tokyo, Japan;
• Prof. Dr. Sang-Woo Kim, Department of Materials Science and Engineering, Yonsei University, Korea;
• Prof. Dr. Chengkuo Lee, Director of Center for Intelligent Sensors and MEMS; Electrical and Computer Engineering, National University of Singapore, Singapore.

Topics of Interest:

• S1. Lab-on-a-Chip (LoC) and MicroTAS;
• S2. Biosensors and Biomedical Devices;
• S3. In-Body IoT Sensing Technology, Electroceuticals and Neural Interfaces;
• S4. Nanophotonics and Metasurface;
• S5. Acoustic, RF, THz Metamaterials and AI-Enabled Metamaterials;
• S6. Neuromorphic Computing, In-Memory Computing and Applications;
• S7. Photonics Integrated Circuits (PICs) and Novel Materials;
• S8. Enabling Technology for Photonic Neural Networks (PNNs) and Applications;
• S9. In-Sensor Computing and Enabling Technology for Edge Computing;
• S10. MEMS/NEMS Sensors;
• S11. Semiconductor Sensors, Photodetectors and CMOS MEMS;
• S12. Piezoelectric MEMS and Resonators—FBAR, SAW and pMUT;
• S13. Piezoelectric Transducers and Energy Harvesters;
• S14. Ferroelectric/Perovskite/2D Materials Thin Film and Applications;
• S15. Gas Sensors and Chemosensors;
• S16. Triboelectric Nanogenerators and Self-Powered Sensors;
• S17. Energy Harvesting Technology and Applications;
• S18. Flexible, Stretchable and Wearable Sensors;
• S19. Wearable AI Sensors;
• S20. AI-Enhanced Tactile Sensors and e-Skin;
• S21. Haptic Technology and Applications;
• S22. Advanced Sensors for Robots and Autonomous Systems;
• S23. Intelligent Sensors and AI-Enhanced Humanoids;
• S24. Enabling Technology for Digital Twin, Metaverse and Smart Sensing Systems;
• S25. AIoT Technology and Applications;
• S26. Sensors for Applications in Agriculture, Aquaculture, Food Technology (A2FT) and Harsh Environment;
• S27. Industry Forum and Commercialization of Sensors and Transducers;
• S28. Regular Symposium.

Guide for Authors:

Please click the button to submit your abstract before 10 May 2025.

Please click the button to register for this event.

For any enquiries regarding the event, please contact ais2025@mdpi.com.

We look forward to seeing you at AIS 2025.

MDPI will attend the XIV International Congress of Dermatology (ICD2025) as an exhibitor. This meeting will be held in Rome, Italy, from 18 to 21 June 2025. 

This congress promises a unique opportunity to engage with leading experts, exchange knowledge on groundbreaking research, and explore the latest advancements in dermatology. The scientific program will cover a wide array of topics, ensuring a comprehensive and enriching experience for all attendees.

The following MDPI journals will be represented at the conference:

• Cosmetics;
• Dermato;
• Diagnostics;
• Dermatopathology;
• Venereology. 

MDPI, a pioneer in scholarly open access publishing, and the Lee Kong Chian School of Medicine (LKCMedicine), Singapore, proudly announce the successful conclusion of the first edition the MDPI Early Career Researcher Awards. The awards, which recognize outstanding contributions to medical and biomedical research, were presented to six exceptional researchers during an awards ceremony held at LKCMedicine HQ Building on 28 November 2024.

Honoring Excellence in Research

The awards recognize exceptional postdoctoral researchers and Ph.D. students who have demonstrated outstanding originality, innovation, and impact in their respective fields. We are honored to announce the winners of the 2024 edition:

Early Career Researcher (Postdoc) Award:

• Dr. Theresia Handayani Mina, “Adiposity and Metabolic Health in Asian Populations: An Epidemiological Study Using Dual-Energy X-Ray Absorptiometry in Singapore”;
• Dr. Erfan Rezvani Ghomi, “Wound Healing Improvement by Novel Aligned Antimicrobial Nanofibrous 3D Scaffolds”;
• Dr. Yadollah Ranjbar Slamloo, “Functional Alterations of The Prefrontal Circuit Underlying Cognitive Aging in Mice”.

Early Career Researcher (Ph.D.) Award:

• Pritisha Rozario, “Mechanistic Basis for Potassium Efflux-Driven Activation of the Human NLRP1 Inflammasome”;

• Michelle Law Cheok Yien, “Chikungunya Virus Nonstructural Protein 1 is a Versatile RNA Capping and Decapping Enzyme”;
• Yin Ruoyu, “The Use of Digital Mental Health and Wellbeing Tools in Older Adults: A Mixed Method Study”.

Our collaboration highlights a shared commitment to recognizing exceptional talent and research within the academic community, addressing today’s healthcare challenges, and inspiring continued innovation.

Looking Ahead to 2025

Building on the success of the first edition, MDPI and LKCMedicine are excited to announce that the 2025 MDPI Early Researcher Awards will continue to celebrate excellence and innovation in medical research. The next edition promises to expand its scope, introducing new categories and providing even greater recognition for impactful research.

Further details on the 2025 awards, including nomination criteria and timelines, will be shared in the coming months. We remain committed to fostering a culture of research excellence and collaboration within the global scientific community.

Cancer impacts millions of lives worldwide, yet each person’s journey with the disease is uniquely their own. World Cancer Day reminds us that while the disease impacts individuals differently, our shared strength, innovation, and focus on holistic care bring us closer to a future where cancer no longer dictates lives. Every experience, challenge, and success story contribute to the broader fight against cancer, demonstrating the resilience and hope that unite us all. As we continue to make strides through innovative research, treatment advancements, and global collaboration, it is essential to recognize both the diversity of stories and our common goal of overcoming cancer together.

In observance of this day, we invite you to explore the following resources that delve into the field of cancer and the cutting-edge advancements shaping its care. By prioritizing people-centered treatment where patients’ voices and needs guide care, we can ensure personalized attention for all. It is our hope to foster a deeper understanding of the impact of cancer and encourage meaningful action to support patients, caregivers, and researchers in their pursuit of a world free from cancer’s hold. Together, we can inspire action and work toward a cancer-free future.

“Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls”
by Celestine M. Trinidad, Sintawat Wangsiricharoen, Victor G. Prieto and Phyu P. Aung
Dermatopathology 2023, 10(1), 54–62; https://doi.org/10.3390/dermatopathology10010008

“Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective”
by Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria Grishina et al.
Pharmaceuticals 2023, 16(2), 299; https://doi.org/10.3390/ph16020299

“Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine”
by Maurizio Cè, Giovanni Irmici, Chiara Foschini, Giulia Maria Danesini, Lydia Viviana Falsitta, Maria Lina Serio, Andrea Fontana, Carlo Martinenghi, Giancarlo Oliva and Michaela Cellina
Curr. Oncol. 2023, 30(3), 2673–2701; https://doi.org/10.3390/curroncol30030203

“Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook”
by Onyinyechi Obidiro, Gantumur Battogtokh and Emmanuel O. Akala
Pharmaceutics 2023, 15(7), 1796; https://doi.org/10.3390/pharmaceutics15071796

“Biomarkers in Breast Cancer: An Old Story with a New End”
by Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, Matheus Correia Casotti, Diego do Prado Ventorim, Jucimara Ferreira Figueiredo Almeida, Valdemir Pereira de Sousa, Marllon Cindra Sant’Ana, Rahna Gonçalves Coutinho da Cruz, Luana Santos Louro et al.
Genes 2023, 14(7), 1364; https://doi.org/10.3390/genes14071364

“Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?”
by Marin Golčić and Andrej Belančić
Diabetology 2023, 4(4), 553–559; https://doi.org/10.3390/diabetology4040049

“Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers”
by Ravi Bharadwaj, Swati Jaiswal, Erandi E. Velarde de la Cruz and Ritesh P. Thakare
Diseases 2024, 12(3), 63; https://doi.org/10.3390/diseases12030063

“Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer”
by Dimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki and Konstantinos G. Toutouzas
Curr. Issues Mol. Biol. 2024, 46(4), 2827–2844; https://doi.org/10.3390/cimb46040177

“Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies”
by Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, Jorge Sastre-Serra, Daniel Gabriel Pons, Adamo Valle, Pilar Roca and Mercedes Nadal-Serrano
Biology 2024, 13(5), 302; https://doi.org/10.3390/biology13050302

“Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions”
by Abdullah Younis and John Gribben
Immuno 2024, 4(3), 186–210; https://doi.org/10.3390/immuno4030013

“Breast Cancer Screening among African Immigrants in the United States: An Integrative Review of Barriers, Facilitators, and Interventions”
by Julian I. Rauch, Joseph Daniels, Alyssa Robillard and Rodney P. Joseph
Int. J. Environ. Res. Public Health 2024, 21(8), 1004; https://doi.org/10.3390/ijerph21081004

“Predicting Leukoplakia and Oral Squamous Cell Carcinoma Using Interpretable Machine Learning: A Retrospective Analysis”
by Salem Shamsul Alam, Saif Ahmed, Taseef Hasan Farook and James Dudley
Oral 2024, 4(3), 386–404; https://doi.org/10.3390/oral4030032